Hussman Strategic Advisors’s QuidelOrtho QDEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
– Sell
-42,000
Closed -$1.21M – 322
2025
Q2
$1.21M Buy
+42,000
New +$1.24M 0.28% 125
2023
Q4
– Sell
-6,200
Closed -$453K – 288
2023
Q3
$453K Hold
6,200
– – 0.09% 244
2023
Q2
$514K Hold
6,200
– – 0.09% 250
2023
Q1
$552K Hold
6,200
– – 0.09% 267
2022
Q4
$531K Hold
6,200
– – 0.09% 253
2022
Q3
$443K Hold
6,200
– – 0.08% 258
2022
Q2
$603K Hold
6,200
– – 0.1% 246
2022
Q1
$697K Hold
6,200
– – 0.14% 219
2021
Q4
$837K Hold
6,200
– – 0.18% 177
2021
Q3
$875K Hold
6,200
– – 0.19% 175
2021
Q2
$794K Buy
6,200
+5,170
+502% +$609K 0.16% 212
2021
Q1
$132K Buy
+1,030
New +$190K 0.03% 315

Other funds holding QDEL

Hussman Strategic Advisors's QDEL Position: Q3 2025 in Review

Hussman Strategic Advisors sold out of QuidelOrtho (QDEL) in Q3 2025, closing a stake of 42,000 shares — an estimated $1.21M sold.

Hussman Strategic Advisors first reported a position in QDEL in Q1 2021 and held it in 12 quarters. The position peaked at $1.21M in Q2 2025. 255 funds tracked by Wall St. Rank hold QDEL as of Q3 2025.

  • Hussman Strategic Advisors reported no remaining QuidelOrtho position as of Q3 2025 after selling out during the quarter.
  • Hussman Strategic Advisors sold 42,000 QuidelOrtho shares in Q3 2025, an estimated $1.21M.
  • Hussman Strategic Advisors first reported a position in QuidelOrtho in Q1 2021 and held it in 12 quarters.
  • Hussman Strategic Advisors's QuidelOrtho position peaked at $1.21M in Q2 2025.
  • 255 funds tracked by Wall St. Rank held QuidelOrtho as of Q3 2025.

Based on Hussman Strategic Advisors's 13F filing for Q3 2025, filed 3 Nov 2025.